Skip to main content


Health

During a phase one clinical trial of a new treatment for MS patients, researchers were able to curtail the body's attacks on myelin by 50 to 75 percent, while sustaining the functionality of the rest of the immune system.
617 of 1826




Newsletter Sign Up



Daily Readings

Reading 1, Colossians 1:1-8
From Paul, by the will of God an apostle of Christ Jesus, and ... Read More

Psalm, Psalms 52:10, 11
Read More

Gospel, Luke 4:38-44
Leaving the synagogue he went to Simon's house. Now Simon's ... Read More

Saint of the Day

September 2 Saint of the Day

St. Ingrid of Sweden
September 2: Born in Skänninge, Sweden, in the 13th century, St. Ingrid lived ... Read More